Gregory B. Lesinski, PhD, MPH

Professor, Co-Director Translational GI Malignancy Program
Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University
Atlanta, Georgia, United States

Presentation(s):

• 54: Galectin-9 is a regulator of immune interactions in the tumor microenvironment and represents a novel therapeutic target in biliary tract cancer.

  Saturday, March 23, 2024
  8:42am – 8:52am ET